New life for cancer drug that reprograms pain pathway to fight chronic pain Chronic pain associated with nerve injury and chronic bone pain from metastatic cancer are unmet medical needs.
A large percentage of medical research gets delayed because researchers cannot get enough patients to participate in clinical trials. It is challenging for researchers to find participants who would qualify,
The National Institutes of Health provides explanations about trials and studies so that you can understand: The difference between clinical trials and studies The four phases of clinical trials Why
Background Biohaven Pharmaceuticals is studying rimegepant, for the treatment of Trigeminal Neuraligia (TN). If you are 18 years or older and suffer from TN, you may qualify. This is a
In March 2021, the article “Microvascular Transposition Without Teflon: A Single Institution’s 17-Year Experience Treating Trigeminal Neuralgia” was published in the peer-reviewed journal Operative Neurosurgery. The senior author and surgeon of